Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antirheumatic Agents”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02584855
What this trial is testing

A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Eli Lilly and Company 394
Early research (Phase 1)Study completedNCT01878123
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
MedImmune LLC 26
Not applicableStudy completedNCT05572567
What this trial is testing

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 1,972
Large-scale testing (Phase 3)Study completedNCT03086343
What this trial is testing

Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 657
Large-scale testing (Phase 3)Study completedNCT01521923
What this trial is testing

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 359
Post-approval studies (Phase 4)UnknownNCT00808496
What this trial is testing

The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis

Who this might be right for
Inflammatory Arthritis
McMaster University 186
Not applicableLooking for participantsNCT04955899
What this trial is testing

Safety of Splenic Stimulation for RA

Who this might be right for
Rheumatoid Arthritis
Galvani Bioelectronics 5
Large-scale testing (Phase 3)Study completedNCT02720523
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 197
Testing effectiveness (Phase 2)Study completedNCT01754935
What this trial is testing

A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509, an Oral JAK3 Inhibitor

Who this might be right for
Rheumatoid Arthritis
Vertex Pharmaceuticals Incorporated 43
Large-scale testing (Phase 3)Study completedNCT00124982
What this trial is testing

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,286
Not applicableNot Yet RecruitingNCT07417995
What this trial is testing

Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic Arthritis

Who this might be right for
Psoriasis Arthritis
Royal United Hospitals Bath NHS Foundation Trust 400
Not applicableStudy completedNCT02240888
What this trial is testing

Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response

Who this might be right for
RASLEVasculitis+3 more
Region Skane 300
Large-scale testing (Phase 3)Study completedNCT01040195
What this trial is testing

Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain

Who this might be right for
Seronegative Spondyloarthropathies
Sanjay Gandhi Postgraduate Institute of Medical Sciences 33
Large-scale testing (Phase 3)Study completedNCT00891020
What this trial is testing

Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 886
Post-approval studies (Phase 4)Study completedNCT01162421
What this trial is testing

A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie (prior sponsor, Abbott) 77
Post-approval studies (Phase 4)Study completedNCT02644499
What this trial is testing

Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Jawaharlal Institute of Postgraduate Medical Education & Research 186
Not applicableStudy completedNCT02648035
What this trial is testing

EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 200
Large-scale testing (Phase 3)Study completedNCT00975130
What this trial is testing

Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)

Who this might be right for
Arthritis, Rheumatoid
Merck Sharp & Dohme LLC 3,366
Large-scale testing (Phase 3)Study completedNCT03155347
What this trial is testing

An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 340
Testing effectiveness (Phase 2)Study completedNCT02049138
What this trial is testing

An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 493
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation